426 - Effectiveness of Updated (2023-2024) Monovalent COVID-19 Vaccines – VISION Network, September 2023-March 2024

Friday, October 18, 2024

3:39 PM – 3:51 PM US PT

Location: 403 B

Presenting Author(s)

Ruth Link-Gelles, PhD, MPH

Epidemiologist
Centers for Disease Control and Prevention
Atlanta, Georgia, United States

Slides

Co-Author(s)

ER

Elizabeth Rowley, DrPH

Senior Biostatistician
Westat
Durham, North Carolina, United States
SR

Sarah E. Reese, PhD

Westat
Rockville, Maryland, United States
OA

Omobosola Akinsete, MD

HealthPartners Institute
Minneapolis, Minnesota, United States
KD

Kristin K. Dascomb, MD. PhD

Medical Director Infection Prevention and Employee Health
Intermountain Healthcare
Murray, Utah, United States
Stephanie Irving, MHS (she/her/hers)

Senior Research Associate
Kaiser Permanente Center for Health Research
Portland, Oregon, United States
Nicola P. Klein, MD, PhD (she/her/hers)

Director, Kaiser Permanente Vaccine Study Center and Senior Research Scientist
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States
SG

Shaun J. Grannis, MD, MS

Indiana University
Indianapolis, Indiana, United States
TO

Toan Ong, PhD

University of Colorado Anschutz Medical Campus
Centennial, Colorado, United States
SB

Sarah W. Ball, MPH, ScD

Westat
Newton, Massachusetts, United States
KF

Katherine E. Fleming-Dutra, MD

Medical Epidemiologist
Centers for Disease Control and Prevention
Atlanta, Georgia, United States
MD

Malini DaSilva, MD, MPH

Research Associate
HealthPartners Institute
Minneapolis, MN, United States
AN

Allison L. Naleway, PhD

Senior Investigator
Kaiser Permanente Center for Health Research
Portland, Oregon, United States
Ousseny Zerbo, PhD

Research Scientist
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, CA, United States
BF

Bruce Fireman, MA

Research Scientist
Division of Research Kaiser Permanente Vaccine Study Center
Oakland, California, United States
BD

Brian E. Dixon, PhD

Director of Public Health Informatics
Regenstrief Institute
Indianapolis, Indiana, United States
KN

Karthik Natarajan, PhD

Columbia University
New York, New York, United States
MT

Mark W. Tenforde, MD, PhD, MPH, DTM&H

Epidemic Intelligence Service Officer
US Centers for Disease Control and Prevention
Decatur, Georgia, United States
Amanda B. Payne, PhD (she/her/hers)

Epidemiologist
CDC
Atlanta, Georgia, United States

Disclosure(s):

Elizabeth Rowley, DrPH: No financial relationships to disclose

Sarah E. Reese, PhD: No financial relationships to disclose

Omobosola Akinsete, MD: No financial relationships to disclose

Nicola P. Klein, MD, PhD: GlaxoSmithKline: Grant/Research Support; Merck: Grant/Research Support; Pfizer: Grant/Research Support; Sanofi Pasteur: Grant/Research Support; Seqirus: Grant/Research Support

Toan Ong, PhD: Patent Title: Systems and Methods For Record Linkage: PCT/US2018/047961 Patent Title: Systems and Methods For Record Linkage; PCORI: Travel support to attend the PCORI Annual meeting in Washington DC, 2023; Regenstrief Institute: Advisor/Consultant, Travel support to attend the OHIE 23 meeting in Malawi.

Sarah W. Ball, MPH, ScD: No financial relationships to disclose

Allison L. Naleway, PhD: No financial relationships to disclose

Ousseny Zerbo, PhD: No financial relationships to disclose

Brian E. Dixon, PhD: Elsevier: Honoraria

Mark W. Tenforde, MD, PhD, MPH, DTM&H: No financial relationships to disclose